Status:
COMPLETED
Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Aortic Regurgitation
Eligibility:
All Genders
Brief Summary
To assess whether cardiac T1 mapping for detection of myocardial fibrosis enables preoperative identification of patients at risk for early left ventricular dysfunction after surgery of aortic regurgi...
Detailed Description
We hypothesized that a diffuse interstitial myocardial fibrosis may be present in AR patients who experience early systolic LV dysfunction after aortic valve surgery. We aimed to evaluate the associat...
Eligibility Criteria
Inclusion
- Consecutive patients with severe aortic regurgitation referred for aortic valve surgery were prospectively enrolled in the study.
Exclusion
- history of coronary artery disease
- acute aortic valve disease (i.e., type A aortic dissection or infectious endocarditis)
- common contraindications for MRI such as severe obesity and metallic foreign bodies.
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05332184
Start Date
July 1 2016
End Date
March 13 2020
Last Update
April 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.